CVE-2022-23917
AI Analysis
Technical Summary
CVE-2022-23917 is a reported vulnerability identifier that was reserved on February 3, 2022, and assigned by Intel. However, according to the provided data, this CVE entry is marked with a state of "REJECTED," indicating that the vulnerability report was either invalid, duplicate, or otherwise not accepted as a valid security issue by the CVE Numbering Authority. There are no technical details, affected versions, or exploit information available for this CVE. No CVSS score has been assigned, and there are no known exploits in the wild. The absence of technical details and the rejected status strongly suggest that this entry does not represent an actual security threat or vulnerability.
Potential Impact
Since CVE-2022-23917 is marked as rejected and lacks any technical details or evidence of exploitation, it poses no known impact to any organizations, including those in Europe. There is no indication of affected systems or software, no confidentiality, integrity, or availability concerns, and no active threat actors exploiting this issue. Therefore, European organizations are not at risk from this CVE.
Mitigation Recommendations
Given that CVE-2022-23917 is a rejected CVE with no valid vulnerability associated, no specific mitigation actions are necessary. Organizations should continue to follow standard cybersecurity best practices, including timely patching of software, monitoring for credible vulnerabilities, and maintaining robust security controls. It is advisable to disregard this CVE entry in vulnerability management processes.
CVE-2022-23917
AI-Powered Analysis
Technical Analysis
CVE-2022-23917 is a reported vulnerability identifier that was reserved on February 3, 2022, and assigned by Intel. However, according to the provided data, this CVE entry is marked with a state of "REJECTED," indicating that the vulnerability report was either invalid, duplicate, or otherwise not accepted as a valid security issue by the CVE Numbering Authority. There are no technical details, affected versions, or exploit information available for this CVE. No CVSS score has been assigned, and there are no known exploits in the wild. The absence of technical details and the rejected status strongly suggest that this entry does not represent an actual security threat or vulnerability.
Potential Impact
Since CVE-2022-23917 is marked as rejected and lacks any technical details or evidence of exploitation, it poses no known impact to any organizations, including those in Europe. There is no indication of affected systems or software, no confidentiality, integrity, or availability concerns, and no active threat actors exploiting this issue. Therefore, European organizations are not at risk from this CVE.
Mitigation Recommendations
Given that CVE-2022-23917 is a rejected CVE with no valid vulnerability associated, no specific mitigation actions are necessary. Organizations should continue to follow standard cybersecurity best practices, including timely patching of software, monitoring for credible vulnerabilities, and maintaining robust security controls. It is advisable to disregard this CVE entry in vulnerability management processes.
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- intel
- Date Reserved
- 2022-02-03T23:50:43.394Z
- Cvss Version
- null
- State
- REJECTED
Threat ID: 68375987182aa0cae258714b
Added to database: 5/28/2025, 6:44:23 PM
Last enriched: 7/7/2025, 5:25:19 AM
Last updated: 7/28/2025, 7:44:22 PM
Views: 8
Related Threats
CVE-2025-8933: Cross Site Scripting in 1000 Projects Sales Management System
MediumCVE-2025-8932: SQL Injection in 1000 Projects Sales Management System
MediumCVE-2025-8931: SQL Injection in code-projects Medical Store Management System
MediumCVE-2025-8930: SQL Injection in code-projects Medical Store Management System
MediumCVE-2025-50610: n/a
HighActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.